BCL2 and cancer: BCL-2 family proteins act as regulators of cell survival in a variety of cancers, including non-small cell lung cancer and breast cancer [17], [18], colon adenocarcinomas [19], clear-cell renal cell carcinoma [20], non-Hodgkin B-cell lymphoma [21], and other hematopoietic malignancies [22].